Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies

Tektonidou, Maria G., Laskari, Katerina, Panagiotakos, Demosthenes B., Moutsopoulos, Haralampos M.·2009·Arthritis Care & Research
DOI 10.1002/art.24232

Cited by (356)

Items 201–300 of 356

  1. Clinical research in systemic lupus erythematosus: immediate relevance to clinical practice
    Michelle Petri · 2011 · International Journal of Rheumatic Diseases
  2. Diffuse alveolar haemorrhage as a rare complication of antiphospholipid syndrome
    Ishith Seth, Shyam Prakaash Bhagavata Srinivasan, Gabriella Bulloch, Dong Seok Yi, Anthony Frankel, Kelvin Hsu, Freda H. Passam, Roger J Garsia, Tamera Jo Corte · 2022 · Respirology Case Reports
  3. The association between ABO blood types and venous thromboembolism in individuals with a positive antiphospholipid profile is varied by sex
    Michael Shusterman, E Golub, Wenzhu Bi Mowrey, Anna R. Broder · 2017 · Lupus
  4. Critical care of the pediatric patient with rheumatic disease
    Andrew I. Shulman, Marilynn Punaro · 2011 · Current Opinion in Pediatrics
  5. Lupus, antiphospholipid syndrome, and stroke: An attempt to crossmatch
    Georges El Hasbani, Imad W. Uthman · 2023 · Lupus
  6. Review on Effectiveness of Primary Prophylaxis in aPLs with and without Risk Factors for Thrombosis: Efficacy and Safety
    Nahid Abdulhamid Qushmaq, Samar A. Al-Emadi · 2014 · ISRN Rheumatology
  7. The ABCs of antiphospholipid syndrome
    Ayşe Bahar Keleşoğlu Dinçer, Doruk Erkan · 2023 · Archives of Rheumatology
  8. Risk Assessment and Antithrombotic Strategies in Antiphospholipid Antibody Carriers
    Ilenia Lorenza Calcaterra, Pasquale Ambrosino, Nicoletta Vitelli, Roberta Lupoli, Roberta Clara Orsini, Martina Chiurazzi, Mauro Maniscalco, Matteo Nicola Dario Di Minno · 2021 · Biomedicines
  9. Solid Phase Immunoassay for the Detection of Anticardiolipin Antibodies
    Rohan Willis, Elizabeth Papalardo, Edward N. Harris · 2017 · Methods in molecular biology
  10. Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus
    D. Paredes, Daniel Martín‐Iglesias, Guillermo Ruiz‐Irastorza · 2023 · Expert Review of Clinical Immunology
  11. Neurological Manifestations of Systemic Lupus Erythematosus: A Comprehensive Review
    Maleesha Jayasinghe, Fatemeh Rashidi, Ahmed Farid Gadelmawla, Jamir Pitton Rissardo, Masoumeh Rashidi, Christopher C Elendu, Ana Letícia Fornari Caprara, Ibrahim Khalil, Khalil Iyad, Mona M. Atef et al. · 2025 · Cureus
  12. Multiple embolic strokes as a result of Libman–Sacks endocarditis associated with lupus and secondary antiphospholipid antibody syndrome: a case report
    Jelena Z. Arnautovic, Hiroshi Yamasaki, Howard Rosman · 2018 · European Heart Journal - Case Reports
  13. Drug monitoring in systemic lupus erythematosus
    Michelle Petri · 2022 · Current Opinion in Pharmacology
  14. Clinical phenotype, treatment strategy and pregnancy outcome of non‐criteria obstetric antiphospholipid syndrome
    Jiapo Li, Yue Hou, Liyang Zhang, Fan Li, Qian Liu, Yuanyuan Li, Hongfei Shen, Ziyue Xiong, Ling Huang, Chong Qiao · 2023 · American Journal of Reproductive Immunology
  15. Antiphospholipidsyndrom
    Christof Specker · 2016 · Zeitschrift für Rheumatologie
  16. Infections Increase Risk of Arterial and Venous Thromboses in Danish Patients with Systemic Lupus Erythematosus: 5102 Patient-years of Followup
    Renata Baronaite Hansen, Søren Jacobsen · 2014 · The Journal of Rheumatology
  17. Antiphospholipid syndrome
    Munther A. Khamashta, Mary‐Carmen Amigo · 2015 · Elsevier eBooks
  18. Deciphering Mechanisms, Prevention Strategies, Management Plans, Medications, and Research Techniques for Strokes in Systemic Lupus Erythematosus
    Ola A Al-Ewaidat, Moawiah M. Naffaa · 2024 · Medicines
  19. Accrual of thromboembolic events and antiphospholipid syndrome in new-onset systemic lupus erythematosus: a population-based inception cohort study
    Sigrid Reppe Moe, Hilde Haukeland, Cathrine Brunborg, Antonela Botea, Nenad Damjanic, Gro Årthun Wivestad, Heidi Kverneggen Øvreås, Thea Bjerkestrand Bøe, Anniken Orre, Torhild Garen et al. · 2025 · RMD Open
  20. Antiphospholipid Syndrome and Kidney Involvement
    Emanuele De Simone, Savino Sciascia, Roberta Fenoglio, Valentina Oddone, Antonella Barreca, Dario Roccatello · 2023 · Kidney & Blood Pressure Research
  21. Hydroxychloroquine in obstetrics: potential implications of the prophylactic use of hydroxychloroquine for placental insufficiency during pregnancy
    Yoo‐Min Kim, Ji‐Hee Sung, Hyun‐Hwa Cha, Soo‐Young Oh · 2024 · Obstetrics & Gynecology Science
  22. Antiphospholipid antibodies as potential prognostic indicators of recurrent ischemic stroke
    Lina Geng, Kai Pan, Yuhuan Xu, Bizhu Zhang, Jing Wang, Qian Xue, Sanming Zhang, Hua Su, Bin Zhang · 2024 · Journal of Stroke and Cerebrovascular Diseases
  23. A Simplified Understanding of the Black Swan: Anti-phospholipid Antibody Syndrome
    Binit Vaidya, Shweta Nakarmi, Rakshya Joshi, Rikesh Baral · 2019 · Journal of Nepal Medical Association
  24. Vasculitic Neuropathies and Neuropathies of Connective Tissue Diseases
    Michael P. Collins, John T. Kissel · 2013 · Springer eBooks
  25. Top 10 Clinical Research Developments in Antiphospholipid Syndrome
    Medha Barbhaiya, Doruk Erkan · 2013 · Current Rheumatology Reports
  26. Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study
    María del Carmen Zamora-Medina, Andrea Hinojosa‐Azaola, Carlos A. Núñez‐Álvarez, Ángel Gabriel Vargas-Ruíz, Juanita Romero‐Díaz · 2018 · Clinical Rheumatology
  27. Glomerular Injury Is Exacerbated in Lupus-Prone MRL/lpr Mice Treated with a Protease-Activated Receptor 2 Antagonist
    Rina Itto, Yuji Oe, Kenta Imaruoka, Emiko Sato, Akiyo Sekimoto, Shu Yamakage, Satoshi Kumakura, Hiroshi Satō, Sadayoshi Ito, Nobuyuki Takahashi · 2019 · The Tohoku Journal of Experimental Medicine
  28. Contraception in Kidney Disease
    Mala Sachdeva · 2020 · Advances in Chronic Kidney Disease
  29. Neuropsychiatric Systemic Lupus Erythematosus: A Remaining Challenge
    Daniel Mrak, Michael Markus Bonelli, Helga Radner · 2022 · Current Pharmaceutical Design
  30. Immunotherapeutic strategies in antiphospholipid syndrome
    Alberta Yik-Bun Hoi, Laura Ross, J. Day, Russell R. C. Buchanan · 2016 · Internal Medicine Journal
  31. Lupus anticoagulant test persistence over time and its associations with future thrombotic events
    Colling, Meaghan E., Ay, Cihan, Kraemmer, Daniel, Koder, Silvia, Quehenberger, Peter, Pabinger, Ingrid, Posch, Florian, Gebhart, Johanna · 2022 · Blood Advances
  32. Venous thromboembolism in patients with lupus nephritis: frequency and risk factors—a cohort study
    Fadi Kharouf, Pankti Mehta, Qixuan Li, Dafna D. Gladman, Laura P Whittall Garcia, Zahi Touma · 2025 · Lara D. Veeken
  33. The well-defined antiphospholipid syndrome induced by COVID-19: a rare case report and review of the literature
    Zong-fang Ren, Ri-cheng Xiong, Lingling Wang, Zhi-huang Chen, Rui Chen, Zhifeng Liu · 2024 · Thrombosis Journal
  34. Non-criteria antiphospholipid antibody profiles and thrombotic outcomes in a cohort of patients with systemic lupus erythematosus
    Alistair W. A. Murray, Eric J. Campbell, Ann Elaine Clarke, Megan R.W. Barber, Tania Pannu, Marvin J. Fritzler, Michelle Jung, Yvan St. Pierre, Leslie Skeith · 2024 · Lupus Science & Medicine
  35. Aortitis is an under-recognized manifestation of antiphospholipid syndrome: A case report and literature review
    Thomas Escoda, Julia George, Pierre‐André Jarrot, Rodolphe Jean, Karin Mazodier, Frederick Sanderson, Pascale Poullin, Ludivine Saby, Noémie Jourde‐Chiche, Gilles Kaplanski et al. · 2022 · Lupus
  36. A Comprehensive Literature Review on Managing Systemic Lupus Erythematosus: Addressing Cardiovascular Disease Risk in Females and Its Autoimmune Disease Associations
    Saleha Dar, Sabina Koirala, Arooba Khan, Mounika Deepthi Bellary, Arya V Patel, Bejoi Mathew, Rahul Singh, Nahida Baigam, Waleed Razzaq, Zain Ul Abdin et al. · 2023 · Cureus
  37. The current standing of diagnosis of antiphospholipid syndrome associated with systemic lupus erythematosus
    Bassem N. Matta, Imad W. Uthman, Ali T. Taher, Munther A. Khamashta · 2013 · Expert Review of Clinical Immunology
  38. Systemic Lupus Erythematosus
    Eleftherios Pelechas, Evripidis Kaltsonoudis, Paraskevi V. Voulgari, Alexandros A. Drosos · 2018 · Springer eBooks
  39. The role of aspirin in the primary prevention of accelerated atherosclerosis in systemic autoimmune rheumatic diseases
    Serena Fasano, Daniela Iacono, Antonella Riccardi, Francesco Ciccia, Gabriele Valentini · 2020 · Rheumatology
  40. Pathogenic Mechanisms of Thrombosis in Antiphospholipid Syndrome (APS)
    Marina P., P. Eleftheria, Georgiadis Panayiotis · 2011 · InTech eBooks
  41. Antiphospholipid Syndrome
    Tadej Avčin, Kathleen M. O’Neil · 2015 · Elsevier eBooks
  42. Atherothrombotic comorbidity in the rheumatic diseases. The evidence becomes clearer. What should clinicians do?
    Inmaculada del Rincón · 2009 · Arthritis Care & Research
  43. Hybrid Treatment of Lower Limb Critical Ischemia in a Patient with Systemic Lupus Erythematosus
    Sotirios Giannakakis, George C. Galyfos, Ioannis Stefanidis, Georgios Kastrisios, Chrisostomos K. Maltezos · 2015 · Annals of Vascular Surgery
  44. Antiphospholipid syndrome
    Nobuya Abe, Tatsuya ATSUMI · 2018 · Japanese Journal of Thrombosis and Hemostasis
  45. Az autoantitest-vizsgálatok jelentősége szisztémás lupus erythematosusban
    Katalin T. Kovács, Gabriella Nagy, Bernadett Halda-Kiss, Gabór Kumánovics · 2022 · Orvosi Hetilap
  46. Antiplatelet effects of hydroxychloroquine in patients with systemic lupus erythematosus evaluated by the total thrombus-formation analysis system (T-TAS)
    Daisuke Hiraoka, Jun Ishizaki, Jun Yamanouchi, Takatsugu Honda, Toshiyuki Niiya, Erika Horimoto, Kenta Horie, Hitoshi Yamasaki, Takuya Matsumoto, Koichiro Suemori et al. · 2024 · Lupus Science & Medicine
  47. Thrombotic antiphospholipid syndrome: From guidelines to clinical management
    D. Paredes, Daniel Martín‐Iglesias, Guillermo Ruiz‐Irastorza · 2024 · Medicina Clínica
  48. Global Antiphospholipid Syndrome Score (GAPSS) in patients with primary antiphospholipid syndrome
    Fariza A. Cheldieva, Tatiana Magomedalievna Reshetnyak, Anastasiia A. Shumilova, Kamila S. Nurbaeva, Mariya V. Cherkasova, Elena Yu. Samarkina, Aleksander M. Lila · 2023 · Modern Rheumatology Journal
  49. A 26‐year‐old white man with a systemic lupus erythematosus flare and acute multiorgan ischemia: Vasculitis or thrombosis?
    Julie Cherian, Roland Duculan, Isabelle Amigues, Mary K. Crow, Kyriakos A. Kirou · 2011 · Arthritis Care & Research
  50. Treatment of antiphospholipid antibody syndrome
    Ali A. Mehdi, Imad W. Uthman, Munther A. Khamashta · 2010 · International Journal of Clinical Rheumatology
  51. Low additive effect of hydroxychloroquine on Japanese patients with systemic lupus erythematosus taking calcineurin inhibitor
    Hironari Hanaoka, Harunobu Iida, Tomofumi Kiyokawa, Yukiko Takakuwa, Kimito Kawahata · 2018 · International Journal of Rheumatic Diseases
  52. Treatment of Systemic Lupus Erythematosus
    George K Bertsias, Antonios Fanouriakis, Dimitrios T. Boumpas · 2013 · Elsevier eBooks
  53. Nonanticoagulant Strategies for Venous Thromboembolism Prophylaxis
    Gerard Gurumurthy, Jecko V. Thachil · 2025 · Seminars in Thrombosis and Hemostasis
  54. Platelet Activation and Autoimmunity: Mechanisms Linking Hemostasis and Cardiovascular Risk in Rheumatologic Disease
    Richard Ni, Tessa J. Barrett, Michael Seth Garshick · 2026 · Journal of the American Heart Association
  55. Saudi National Clinical Practice Guidelines for Management of Adult Systemic Lupus Erythematosus
    Ahmed H. Al-Jedai, Hajer Almudaiheem, Ibrahim Abdulrazag Al-Homood, Ibrahim A. AlMaghlouth, Sami M. Bahlas, Abdulaziz Mohammed Alolaiwi, Mohammad Ibrahim Ahmad Fatani, Maysa Tariq Eshmawi, Bedor A. Al-Omari, Khalidah Ahmed Owdetallah Alenzi et al. · 2024 · Current Rheumatology Reviews
  56. Elucidating the mechanisms and efficacy of antimalarial drugs in systemic lupus erythematosus
    D. Paredes, Daniel Martín‐Iglesias, Laura Amo, Guillermo Ruiz‐Irastorza · 2024 · Expert Opinion on Pharmacotherapy
  57. Pulmonary Manifestations of Systemic Lupus Erythematosus (SLE)
    Shikha Mittoo, Jeffrey J. Swigris · 2014 · Springer eBooks
  58. Treatment of Systemic Lupus Erythematosus
    George K Bertsias, Antonis Fanouriakis, Dimitrios T. Boumpas · 2016 · Elsevier eBooks
  59. A review on management of antiphospholipid syndrome in clinical practice
    Carmine Siniscalchi, Pietro Rossetti, Gaetano Carolla, Pierpaolo Di Micco, Adriano Stella, Michele Augusto Riva · 2023 · Italian Journal of Medicine
  60. Addressing challenges in pediatric thrombosis: a comprehensive guideline development
    Yin Wang, Qinan Yin, Jace Liao, Na Wang, Li Li, Siyan Li, Qingxia Zhang, Feifei Yu, Jianchun Luo, Hongmei Wang et al. · 2025 · Frontiers in Pediatrics
  61. A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report
    Takaya Takeuchi, Yunosuke Matsuura, Yoshimasa Yamamura, Momoko Ohkusu, Shohei Koyama, Takeshi Kawaguchi, Mayumi Akaki Nagayasu, Hiroyuki Komatsu, Akihiko Okayama, Tetsunori Ishikawa et al. · 2021 · Clinical Case Reports
  62. Nephrotic syndrome in adults: symptoms and management
    2021 · Pharmaceutical journal/The pharmaceutical journal
  63. Prevalence of Annexin A5 Resistance in Children and Adolescents with Rheumatic Diseases
    Dawn M. Wahezi, Norman T. Ilowite, Swapnil N. Rajpathak, Jacob H. Rand · 2011 · The Journal of Rheumatology
  64. Abdominal pain in systemic lupus erythematosus: lupus enteritis, mesenteric thrombosis, or median arcuate ligament syndrome?
    Narainraj Kamalaraj, T Tsai, David Massasso · 2014 · Scandinavian Journal of Rheumatology
  65. Pulmonary Manifestations of Systemic Lupus Erythematosus
    Hilary J. Goldberg, Paul F. Dellaripa · 2012 · Springer eBooks
  66. Antimalarials and SLE
    Nathalie Costedoat-Chalumeau, Gaëlle Leroux, J.C. Pietté, Zahir Amoura · 2011 · Elsevier eBooks
  67. Systemic lupus erythematosus with repeated protein-losing enteropathy resulting from different pathological conditions: a case report
    Masashi Funada, Kazuhisa Nakano, Ippei Miyagawa, Masanobu Ueno, Yoshiya Tanaka · 2020 · Modern Rheumatology Case Reports
  68. Response to: 'Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial–comment on: 'Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus' by Chatzidionysiou et al' by Bettiol et al
    Katerina Chatzidionysiou, Evangelia Samoli, Petros Paul Sfikakis, Maria G. Tektonidou · 2020 · Annals of the Rheumatic Diseases
  69. KDIGO 2024 Clinical Practice Guideline for the management of lupus nephritis. Translated into Russian by E.V. Zakharova
    Article Editorial · 2024 · Nephrology and Dialysis
  70. aPLs seroconversion in antiphospholipid syndrome: from definition to clinical relevance
    Angela Di Giorgio, Claudia Carnuccio, Antonio Nesci, Valerio De Stefano, Angelo Santoliquido · 2026 · Thrombosis Research
  71. Efficacy and safety of low-dose acetylsalicylic acid for the prevention of thromboembolic events in individuals positive for antiphospholipid antibodies: A systematic review and meta-analysis
    Federica De Pascali, Yulia Aleksandrovna Filippova, Marco Paolo Donadini, Vittorio Pengo, Alessandro Squizzato · 2024 · Thrombosis Research
  72. Does COVID-19 infection or COVID-19 mRNA vaccination induce antiphospholipid antibodies in women with recurrent pregnancy loss?
    Toshiyuki Takeshita, Naomi Nishimiya, Yachika Hihara · 2025 · Journal of Reproductive Immunology
  73. Antiphospholipid Antibodies and Syndrome: Complexities in Diagnosis and Management
    Karen Ingrid Schreiber, Savino Sciascia, Beverley Jane Hunt · 2016 · Springer eBooks
  74. A new role for antimalarials in systemic lupus erythematosus treatment
    Jose-Luis Ayensa, Munther A. Khamashta, Guillermo Ruiz‐Irastorza · 2010 · International Journal of Clinical Rheumatology
  75. Clinical Aspects of the Antiphospholipid Syndrome
    Aisha Lateef, Michelle Petri · 2012 · Elsevier eBooks
  76. Antiphospholipid Syndrome
    Bonnie Lee Bermas · 2012 · Springer eBooks
  77. Pulmonary manifestations of systemic lupus erythematosus
    Juan Vicente Rodriguez, Tracy Jennifer Doyle, Paul F. Dellaripa · 2021 · Elsevier eBooks
  78. Vitamin D in Lupus Patients of Childbearing Age: Are We Doing Enough?
    Gianina Statache, Sadaf Brown · 2022 · Frontiers in Reproductive Health
  79. Brainstem stroke in a patient with systemic lupus erythematosus and triple antiphospholipid antibody profile
    Anna Zolyan, John Ross Crawford · 2022 · BMJ Case Reports
  80. Thrombotic risk assessment in patients with systemic lupus erythematosus: Validation of the adjusted‐Global Antiphospholipid Syndrome Score (aGAPSS) in Thai patients
    Wanitcha Chanloung, Nuntana Kasitanon, Ramjai Wichainun, Worawit Louthrenoo · 2021 · International Journal of Rheumatic Diseases
  81. Hydroxychloroquine in Systemic Lupus Erythematosus: Comment on the Article by Muangchan et al
    Martin Michaud, F. Gaches · 2015 · Arthritis Care & Research
  82. Antiphospholipid Syndrom
    2019 · rheuma plus
  83. Thrombotic microangiopathy due to primary antiphospholipid syndrome: successful treatment with eculizumab
    Chiara Pala, Elisabetta Parenti, Giuseppe Vizzini, Davide Gianfreda, Giovanni Maria Rossi · 2023 · Journal of Nephrology
  84. Clinical recommendations on diagnostics and treatment of lupus nephritis (draft project)
    Elena Zakharova, N.L. Kozlovskaya, Yulia V. Korotchaeva, Irina Nikolaevna Bobkova, Vladimir Dobronravov, A. V. Karunnaya · 2024 · Nephrology and Dialysis
  85. Multidisciplinary Approach in Libman–Sacks Endocarditis
    Vikyath Satish, Maisha Maliha, Shalom Rosenbaum, Vishakha Modak, Kuan‐Yu Chi, Ephraim Leiderman · 2025 · Case Reports in Cardiology
  86. Hydroxychloroquine sulfate tablets for patients with recurrent implantation failure: a double-blind, randomized, placebo-controlled trial
    Dong-Lin Han, Lei Li, Jing Shi, Yimeng Ge, Shu-Lin Yang, Yifan Chu, Zhuo-Yao Mai, Y. L. Zhang, Hui Chen, Yue Jing et al. · 2026 · Trials
  87. Disease-activity-linked complement-coagulation interactions and persistent platelet activation in treatment-naïve systemic lupus erythematosus
    Mads Lamm Larsen, Fatih Demir, Henrik Zachar Langkilde, Petrus Linge, Elsa Grenmyr, Ellen‐Margrethe Hauge, Anne Voss, Markus Matthias Rinschen, Anders A Bengtsson, Julie Brogaard Larsen et al. · 2026 · Journal of Autoimmunity
  88. ¿Se deben tratar preventivamente los pacientes asintomáticos con anticuerpos antifosfolípidos?
    Paula Estrada, Carmen Gómez‐Vaquero, Laura López Vives, Javier Narváez · 2012 · Seminarios de la Fundación Española de Reumatología
  89. OBSTETRIC ANTIPHOSPHOLIPID SYNDROME - A REVIEW
    Karen Ingrid Schreiber, Oier Ateka–Barrutia, Munther A. Khamashta, GRV Hughes · 2011 · Fetal and Maternal Medicine Review
  90. What are the Potential Future Treatments in Antiphospholipid Syndrome?
    Doruk Erkan, Anisur Rahman, Hannah Cohen, Samuel J. Machin, Silvia S. Pierangeli · 2012 · Springer eBooks
  91. CME CVD in SLE Accelerated cardiovascular disease in patients with lupus: A review
    Laura M. Seavy, John M. Grosel · 2012 · JAAPA
  92. Conventional Treatment of Systemic Lupus Erythematosus
    Giacomo Quattrocchio, Fernando Custodio Fervenza, Dario Roccatello · 2016 · Rare diseases of the immune system
  93. Hereditary Spherocytosis and Venous Thrombosis of Atypical Site: A Triple Hematologic Disease?
    Santiago Andrés Guzmán García, Gonzalo Anwar Montalvo, Anwar García Santos, Ana Karen Valenzuela Vidalez, Emilio Conde Flores, Aldo Lara Reyes, Leslie Rocha, Brenda Reynoso, Luis Guevara-Arnal, Sergio Arturo Sánchez‐Guerrero · 2016 · Journal of Hematology and Blood Disorders
  94. Primary Prophylaxis in Patients With Positive Antiphospholipid Antibodies
    María José Cuadrado · 2016 · Technical report
  95. The clinical value of measuring antiphospholipid antibodies in high risk primigravidae and nullipara, a case control study
    Amr Adel Mansy, Nermeen N. Al-Gizawi, Abd-El-Latif A Gaballah, Noha AbdEl El-Sawi, Wessam AL-Gendi · 2017 · International Journal of Reproduction Contraception Obstetrics and Gynecology
  96. The scoring system for the risk-stratification in patients with the antiphospholipid syndrome
    Kenji Oku · 2017 · Japanese Journal of Clinical Immunology
  97. Task Force Report on the Management of Thrombosis in Antiphospholipid Syndrome
    Guillermo Ruiz‐Irastorza, Vittorio Pengo, Maria G. Tektonidou, Ioana Ruiz‐Arruza, María José Cuadrado, Munther A. Khamashta · 2012 · Springer eBooks
  98. Manifestaciones clínicas y desenlaces maternos y perinatales en gestantes con síndrome antifosfolípido obstétrico de una institución de alta complejidad: estudio descriptivo
    Carolina Restrepo Ocampo, Laura Arango Gutiérrez, Libia María Rodríguez Padilla, Miguel Antonio Mesa Navas, Carlos Jaime Velásquez Franco, Jorge Hernán Gutiérrez-Marín, María Nazareth Campo Campo · 2020 · Revista Colombiana de Reumatología
  99. Spinal and cerebral hematoma in systemic lupus erythematosus and antiphospholipid syndrome: is drug interaction the culprit?
    Emine Duran, Emre Bılgın, Ertuğrul Çağrı Bölek, Oğuzhan Fırat, Elif Bulut, Umut Kalyoncu, Sedat Kiraz, Ömer Karadağ · 2020 · Drug metabolism and drug interactions
  100. Síndrome antifosfolipídico en pediatría: a propósito de un caso
    Miranda Fernández, Paula Tasso, Ignacio Tedeschini, Julia Lómez, María V López, Ariel Cheistwer · 2021 · Archivos Argentinos de Pediatria